Clinical analysis of the usefulness of letermovir for prevention of cytomegalovirus infection after haploidentical hematopoietic stem cell transplantation

被引:0
|
作者
马瑞
机构
[1] Peking Univ Instit Hematol
[2] Peking Univ People’s Hosp
[3] Hematopoietic Stem Cell Transplant
[4] Beijing Key Lab
[5] Natl Clin Hematol Dis Res Center
关键词
D O I
暂无
中图分类号
R457.7 [骨髓移植];
学科分类号
摘要
Objective To analyze the efficacy and safety of letermovir in primary prophylaxis of cytomegalovirus(CMV) reactivation in patients receiving haploidentical hematopoietic stem cell transplantation.Methods This retrospective,cohort study was conducted using data of patients who underwent haploidentical transplantation at Peking University Institute of Hematology and received letermovir for primary prophylaxis between May 1,
引用
收藏
页码:232 / 232
页数:1
相关论文
共 50 条
  • [21] Letermovir for prevention of cytomegalovirus infection in allogeneic stem cell transplant receivers
    Herrera, Fabian
    Torres, Diego
    Querci, Marcia
    Bonvehi, Pablo
    Temporiti, Elena
    Duarte, Patricio
    Videla, Cristina
    Riera, Leandro
    REVISTA CHILENA DE INFECTOLOGIA, 2023, 40 (04): : 328 - 333
  • [22] Pharmacokinetic drug evaluation of letermovir prophylaxis for cytomegalovirus in hematopoietic stem cell transplantation
    Deleenheer, Barbara
    Spriet, Isabel
    Maertens, Johan
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (12) : 1197 - 1207
  • [23] Cidofovir, a choice for salvage treatment of cytomegalovirus infection in patients with haploidentical hematopoietic stem cell transplantation
    Yin, Zhao
    Sun, Jing
    Yang, Ying
    Xu, Na
    Jiang, Ling
    Fan, Zhiping
    Huang, Fen
    Shi, Pengcheng
    Wang, Zhixiang
    Xuan, Li
    Xu, Jun
    Liu, Qifa
    Yu, Guopan
    TRANSPLANT INFECTIOUS DISEASE, 2022, 24 (02)
  • [24] Cytomegalovirus Viremia and Relapse after Haploidentical Hematopoietic Cell Transplantation
    Goldsmith, Scott R.
    Slade, Michael
    Lawrence, Steven J.
    DiPersio, John F.
    Westervelt, Peter
    Uy, Geoffrey L.
    Dubberke, Erik
    Gao, Feng
    Romee, Rizwan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S320 - S320
  • [25] Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection
    Katsuto Takenaka
    Shigeo Fuji
    Toshihiro Matsukawa
    Naoyuki Uchida
    Takeshi Kobayashi
    Masatsugu Tanaka
    Takahide Ara
    Kazuhiro Ikegame
    Yukiyasu Ozawa
    Yoshinobu Kanda
    Masashi Sawa
    Yumiko Maruyama
    Takahiro Fukuda
    Hirohisa Nakamae
    Takafumi Kimura
    Masao Ogata
    Sachiko Seo
    Yoshiko Atsuta
    Keitaro Matsuo
    Hideki Nakasone
    Annals of Hematology, 2024, 103 : 285 - 296
  • [26] Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection
    Takenaka, Katsuto
    Fuji, Shigeo
    Matsukawa, Toshihiro
    Uchida, Naoyuki
    Kobayashi, Takeshi
    Tanaka, Masatsugu
    Ara, Takahide
    Ikegame, Kazuhiro
    Ozawa, Yukiyasu
    Kanda, Yoshinobu
    Sawa, Masashi
    Maruyama, Yumiko
    Fukuda, Takahiro
    Nakamae, Hirohisa
    Kimura, Takafumi
    Ogata, Masao
    Seo, Sachiko
    Atsuta, Yoshiko
    Matsuo, Keitaro
    Nakasone, Hideki
    ANNALS OF HEMATOLOGY, 2023, 103 (1) : 285 - 296
  • [27] A Predicted Model for Refractory/Recurrent Cytomegalovirus Infection in Acute Leukemia Patients After Haploidentical Hematopoietic Stem Cell Transplantation
    Shen, Meng-Zhu
    Hong, Shen-Da
    Wang, Jie
    Zhang, Xiao-Hui
    Xu, Lan-Ping
    Wang, Yu
    Yan, Chen-Hua
    Chen, Huan
    Chen, Yu-Hong
    Han, Wei
    Wang, Feng-Rong
    Wang, Jing-Zhi
    Liu, Kai-Yan
    Huang, Xiao-Jun
    Mo, Xiao-Dong
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [28] Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
    Marty, F. M.
    Ljungman, P.
    Chemaly, R. F.
    Maertens, J.
    Dadwal, S. S.
    Duarte, R. F.
    Haider, S.
    Ullmann, A. J.
    Katayama, Y.
    Brown, J.
    Mullane, K. M.
    Boeckh, M.
    Blumberg, E. A.
    Einsele, H.
    Snydman, D. R.
    Kanda, Y.
    DiNubile, M. J.
    Teal, V. L.
    Wan, H.
    Murata, Y.
    Kartsonis, N. A.
    Leavitt, R. Y.
    Badshah, C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (25): : 2433 - 2444
  • [29] Hepatitis E Virus Infection after Haploidentical Hematopoietic Stem Cell Transplantation:Incidence and Clinical Course
    Tang, Fei-Fei
    Mo, Xiao-Dong
    Wang, Yu
    Yan, Chen-Hua
    Chen, Yu-Hong
    Chen, Huan
    Han, Wei
    Chang, Ying-Jun
    Zhang, Hai-Ying
    Xie, Yan-Di
    Ma, Hui
    Wei, Lai
    Xu, Lan-Ping
    Huang, Xiao-Jun
    Zhang, Xiaohui
    BLOOD, 2018, 132
  • [30] Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation
    Chemaly, Roy F.
    Ullmann, Andrew J.
    Stoelben, Susanne
    Richard, Marie Paule
    Bornhaeuser, Martin
    Groth, Christoph
    Einsele, Hermann
    Silverman, Margarida
    Mullane, Kathleen M.
    Brown, Janice
    Nowak, Horst
    Koelling, Katrin
    Stobernack, Hans P.
    Lischka, Peter
    Zimmermann, Holger
    Ruebsamen-Schaeff, Helga
    Champlin, Richard E.
    Ehninger, Gerhard
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (19): : 1781 - 1789